STAT China: Two more Hong Kong IPO filings, and Beijing’s latest drug price cuts
A version of this digest first appeared in the weekly STAT China newsletter. To receive future editions, sign up here.
Happy Tuesday and welcome back to STAT China. In this edition, two more Hong Kong IPO filings, Beijing’s latest drug price cuts, and a renewed patent feud in the genomics space.
